Contact us for free information or to start a free case review.
Eli Lilly and Co. is already under federal investigation for possible improper marketing of an osteoporosis drug, but now, the government may also look into the way Zyprexa antipsychotic drug was promoted as well. The entire class of neurological antipsychotic medications has attracted attention by regulators. For Eli Lilly, a Zyprexa investigation could greatly affect the drug company. Zyprexa has accounted for sales of $4.3 billion in 2003 alone, which is about a third of overall sales at the company.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.